Literature DB >> 11313908

Transforming G proteins.

V Radhika1, N Dhanasekaran.   

Abstract

Heterotrimeric guanine nucleotide binding proteins, commonly known as G proteins form a super-family of signal transduction proteins. They are peripherally associated with the plasma membrane and provide signal coupling to seven transmembrane surface receptors. G proteins are composed of monomers of alpha, beta, and gamma subunits. The beta- and gamma-subunits are tightly associated. The receptors activated by the appropriate "signal", interact catalytically with specific G-proteins to mediate guanine nucleotide exchange at the GDP/GTP binding site of the G-protein alpha-subunits, thus displacing the bound GDP for GTP. The GTP bound form of the g-protein alpha-subunit and in some cases the free betagamma-subunits initiate cellular response by altering the activity of specific effector molecules. Recent studies have indicated that the asyncronous activation of these proteins can lead to the oncogenic transformation of different cell types. The mechanism by which G-proteins regulate the various cell functions appear to involve a complex net-working between different signaling pathways. This review summarizes the signaling mechanisms involved in the regulation of cell proliferation by these transforming G proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313908     DOI: 10.1038/sj.onc.1204274

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  Identification of 20 novel SNPs in the guanine nucleotide binding protein alpha 12 gene locus.

Authors:  Aritoshi Iida; Susumu Saito; Akihiro Sekine; Wataru Tabei; Yukie Kataoka; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

Review 2.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

3.  Design of cyclic peptides that bind protein surfaces with antibody-like affinity.

Authors:  Steven W Millward; Stephen Fiacco; Ryan J Austin; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

Review 4.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 5.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

6.  Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation.

Authors:  Joachim H C Orth; Inga Preuss; Ines Fester; Andreas Schlosser; Brenda A Wilson; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

7.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

8.  Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF.

Authors:  Raja Bhattacharyya; Philip B Wedegaertner
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.

Authors:  Joachim H C Orth; Ines Fester; Peter Siegert; Markus Weise; Ulrike Lanner; Shigeki Kamitani; Taro Tachibana; Brenda A Wilson; Andreas Schlosser; Yasuhiko Horiguchi; Klaus Aktories
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

10.  Mutational profile of GNAQQ209 in human tumors.

Authors:  Simona Lamba; Lara Felicioni; Fiamma Buttitta; Fonnet E Bleeker; Sara Malatesta; Vincenzo Corbo; Aldo Scarpa; Monica Rodolfo; Margaret Knowles; Milo Frattini; Antonio Marchetti; Alberto Bardelli
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.